Cargando…
Differential sensitivity of prostate tumor derived endothelial cells to sorafenib and sunitinib
BACKGROUND: Prostate cancer is the second leading cause of male cancer death in developed countries. Although the role of angiogenesis in its progression is well established, the efficacy of anti-angiogenic therapy is not clearly proved. Whether this could depend on differential responses between tu...
Autores principales: | Fiorio Pla, Alessandra, Brossa, Alessia, Bernardini, Michela, Genova, Tullio, Grolez, Guillaume, Villers, Arnaud, Leroy, Xavier, Prevarskaya, Natalia, Gkika, Dimitra, Bussolati, Benedetta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295225/ https://www.ncbi.nlm.nih.gov/pubmed/25494980 http://dx.doi.org/10.1186/1471-2407-14-939 |
Ejemplares similares
-
Transient Receptor Potential Channel Expression Signatures in Tumor-Derived Endothelial Cells: Functional Roles in Prostate Cancer Angiogenesis
por: Bernardini, Michela, et al.
Publicado: (2019) -
TRPM8 inhibits endothelial cell migration via a non-channel function by trapping the small GTPase Rap1
por: Genova, Tullio, et al.
Publicado: (2017) -
Effect of the monoclonal antibody TRC105 in combination with Sunitinib on renal tumor derived endothelial cells
por: Brossa, Alessia, et al.
Publicado: (2018) -
Sunitinib but not VEGF blockade inhibits cancer stem cell endothelial differentiation
por: Brossa, Alessia, et al.
Publicado: (2015) -
Alternative Strategies to Inhibit Tumor Vascularization
por: Brossa, Alessia, et al.
Publicado: (2019)